Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: Implications for therapy

Diabetes

Volumn 59, Issue 11, 2010, Pages 2697-2707

  Rizza, Robert A ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOKINASE; GLUCOSE; INSULIN;

ARTICLE; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCOSURIA; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTESTINAL ABSORPTION; LIVER; POSTPRANDIAL PERIOD; REFERENCE VALUES; URIDINE DIPHOSPHATE GLUCOSE;

EID: 78049259220     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1032     Document Type: Article

References (38)

1. Butler PC, Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 1991;40:73-81
2. Reaven GM, Chen Y-DI, Coulston AM, Greenfield MS, Hollenbeck C, Lardinois C, Liu G, Schwartz H. Insulin secretion and action in noninsulin-dependent diabetes mellitus. Am J Med 1983;30:85-93
3. Müller WA, Faloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes: response to carbohydrate and protein ingestion. N Engl J Med 1970;283:109-115
4. Gerich JE, Lorenzi M, Karam JH, Schneider V, Forsham PH. Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus. JAMA 1975;234:159-165
5. Perley M, Kipnis DM. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966;15:867-874
6. Porte D Jr. Banting lecture 1990: β-cells in type II diabetes mellitus. Diabetes 1991;40:166-180
7. Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P, Tager H, Rubenstein A. The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 1986;35:379-386
8. Knop FK, Vilsbøll T, Madsbad S, Holst JJ, Krarup T. Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus. Diabetologia 2007;50:797-805 (Pubitemid 46355821)
9. Dinneen S, Gerich J, Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992;327:707-713
10. Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus: role of hepatic and extrahepatic tissues. J Clin Invest 1986;77:1525-1532
11. Bergman RN, Bucolo RJ. Interaction of insulin and glucose in the control of hepatic glucose balance. Am J Physiol 1974;227:1314-1322
12. Cherrington AD, Williams PE, Harris MS. Relationship between the plasma glucose level and glucose uptake in the conscious dog. Metabolism 1978;27:787-791
13. Myers SR, Diamond MP, Adkins-Marshall BA, Williams PE, Stinsen R, Cherrington AD. Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism 1991;40:66-71
14. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983;32:35-45 (Pubitemid 13203694)
15. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 2004;53:2042-2050 (Pubitemid 38970753)
16. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 2000;49:272-283
17. Wajngot A, Chandramouli V, Schumann WC, Efendic S, Landau BR. Quantitation of glycogen/glucose-1-P cycling in liver. Metabolism 1991;40:877-881
18. Pilkis SJ, Weber IT, Harrison RW, Bell GI. Glucokinase: structural analysis of a protein involved in susceptibility to diabetes. J BiolChem 1994;269:21925-21928
19. Seoane J, Barberà A, Télémaque-Potts S, Newgard CB, Guinovart JJ. Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J Biol Chem 1999;274:31833-31838 (Pubitemid 129503768)
20. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL. Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 1995;27:19-22
21. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 1996;98:1755-1761 (Pubitemid 26359191)
22. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-1246 (Pubitemid 15206819)
23. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001;50:810-816
24. Tappy L, Acheson K, Curchod B, Schneiter P, Normand S, Pachiaudi C, Temler E, Riou JP, Jéquier E. Overnight glucose metabolism in obese non-insulin-dependent diabetic patients and in healthy lean individuals. Clin Physiol 1994;14:251-265
25. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus: a 13C nuclear magnetic resonance study. J Clin Invest 1992;90:1323-1327
26. Radziuk J, Pye S. Production and metabolic clearance of glucose under basal conditions in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 2001;44:983-991
27. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988;37:15-21
28. Basu R, Schwenk WF, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 2004;287:E55-E62
29. Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR, Rizza RA. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 2007;56:1703-1711
30. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996;98:378-385 (Pubitemid 26255737)
31. 2O to measure gluconeogenesis in humans. Diabetes 2008;57:50-55
32. Basu R, Chandramouli V, Schumann W, Basu A, Landau BR, Rizza RA. Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes 2009;58:1539-1543
33. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 1998;101:1203-1209 (Pubitemid 28145235)
34. Basu A, Alzaid A, Dinneen S, Caumo A, Cobelli C, Rizza RA. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 1996;97:2351-2361 (Pubitemid 26165724)
35. Gerich JE, Tsalikian E, Lorenzi M, Schneider V, Bohannon NV, Gustafson G, Karam JH. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin. J Clin Endocrinol Metab 1975;41:1178-1180
36. Shah P, Basu A, Basu R, Rizza R. Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol Endocrinol Metab 1999;277:E283-E290
37. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 2005;54:1942-1948 (Pubitemid 40911255)
38. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 2001;50:1351-1362